CHAIR: Mark Johnston, MD, FRCPC
CHAIR: Mark Johnston, MD, FRCPCDirector CNS Research/Medical Director, Atlantic
Centricity Research
Joshua Woolley, MD, Ph.D.
Joshua Woolley, MD, Ph.D.Associate Professor, Psychiatry
UCSF Weill Institute for Neurosciences
Gul Dolen, MD, Ph.D.
Gul Dolen, MD, Ph.D.Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center
Johns Hopkins University
Gary Kay, Ph.D.
Gary Kay, Ph.D.Co-Founder & Chief Scientific Officer
Cognitive Research Corporation
Tim Schlidt
Tim SchlidtCo-founder & Partner
Palo Santo
Boris Heifets, MD, Ph.D.
Boris Heifets, MD, Ph.D.Assistant Professor of Anesthesiology, Perioperative & Pain Medicine
Stanford University
Ryan Gumpper, Ph.D.
Ryan Gumpper, Ph.D.Postdoctoral Research Associate and Project Manager of DARPA Focused Pharma Initiative
Univ. of North Carolina Chapel Hill
Amanda Way
Amanda WayPrincipal

Jazz Venture Partners

Natalie Gukasyan, MD
Natalie Gukasyan, MDAssistant Prof., Dept. of Psychiatry & Behavioral Sciences, Medical Dir., Center for Psychedelic & Consciousness Research
Johns Hopkins University School of Medicine
James Kuo, MD, MBA
James Kuo, MD, MBAVice President of R&D
Silo Pharma
Sabrina Ramkellawan, CCRP, CCRA
Sabrina Ramkellawan, CCRP, CCRAChief Operating Officer & Co-Founder
AxialBridge (formerly known as Knowde Group)
Natasha Sumner, JD
Natasha Sumner, JDSenior Counsel
Husch Blackwell
Kimberly Chew, JD
Kimberly Chew, JDSenior Counsel
Husch Blackwell
Tom McDonald
Tom McDonaldChief Executive Officer
Clerkenwell Health
Anne Dwane
Anne DwanePartner
Village Global
Matthew Baggott, Ph.D.
Matthew Baggott, Ph.D.Co-founder & Chief Executive Officer
Dana Watt, Ph.D.
Dana Watt, Ph.D.Principal
Breakout Ventures
Sandeep Nayak, MD
Sandeep Nayak, MDAssistant Professor, Department of Psychiatry & Behavioral Sciences, Behavioral Pharmacology Research Unit
Johns Hopkins Center for Psychedelic and Consciousness Research
Karen Luong, JD
Karen Luong, JDSenior Counsel
Husch Blackwell
Elliot Marseille, DrPH, MPP
Elliot Marseille, DrPH, MPPDirector

UC Berkeley/UCSF Global Initiative for Psychedelic Science Economics


Health Strategies International

Hailey Gilmore, MPH
Hailey Gilmore, MPHMedical Affairs Program Manager
MAPS Public Benefit Corporation
Graham Pechenik, JD
Graham Pechenik, JDFounder, Patent Attorney
Calyx Law
Christine Moore, Ph.D.
Christine Moore, Ph.D.VP, Neuroscience, Scientific Solutions
Worldwide Clinical Trials
Anton Avanceña, Ph.D.
Anton Avanceña, Ph.D.Assistant Professor of Health Outcomes
University of Texas at Austin College of Pharmacy
James Lanthier
James LanthierChief Executive Officer
Mindset Pharma
Clare Knight
Clare KnightSenior Clinical Trials Manager
Clerkenwell Health
Harpreet Kaur, Ph.D.
Harpreet Kaur, Ph.D.Vice President of Research
PharmAla Biotech
Brett Waters
Brett WatersCo-Founder & Executive Director

Reason for Hope

Associate Attorney

Winston & Strawn

Charlotte Smith, Ph.D.
Charlotte Smith, Ph.D.Associate Professor in Management and Organisation, School of Business
University of Leicester
Matthew Zorn
Matthew ZornPartner
Yetter Coleman
Benjamin Lightburn
Benjamin LightburnCEO & Co-Founder
Filament Health
Gisele Fernandes-Osterhold, MFT
Gisele Fernandes-Osterhold, MFTDirector of Psychedelic Facilitation, Translational Psychedelic Research Program (TrPR), BAND Lab

University of California San Francisco

Shahin Shams
Shahin ShamsData Curator
Porta Sophia
Greg Dwulet
Greg DwuletPatent Agent
Calyx Law
Matias Serebrinsky
Matias SerebrinskyCo-Founder
Psymed Ventures
Max Vargas
Max VargasPh.D. Candidate, Neuroscience Graduate Program
University of California, Davis

About Us

Arrowhead Conferences offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward.


Contact Details

+1 866-945-0263


Organized By